Okabena Investment Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-73
Closed -$10.8K 137
2023
Q3
$10.8K Sell
73
-885
-92% -$160K 0.01% 86
2023
Q2
$209K Hold
958
0.15% 59
2023
Q1
$210K Sell
958
-5,282
-85% -$1.15M 0.15% 65
2022
Q4
$1.67M Buy
6,240
+1,362
+28% +$299K 1.1% 29
2022
Q3
$1.06M Hold
4,878
0.51% 55
2022
Q2
$1.02M Buy
4,878
+190
+4% +$40.4K 0.53% 47
2022
Q1
$1.14M Hold
4,688
0.48% 55
2021
Q4
$1.22M Buy
+4,688
New +$1.22M 0.46% 53

Other funds holding RMD

Okabena Investment Services's RMD Position: Q4 2023 in Review

Okabena Investment Services sold out of ResMed (RMD) in Q4 2023, closing a stake of 73 shares — an estimated $10.8K sold.

Okabena Investment Services first reported a position in RMD in Q4 2021 and held it in 8 quarters. The position peaked at $1.67M in Q4 2022. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Okabena Investment Services reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
  • Okabena Investment Services sold 73 ResMed shares in Q4 2023, an estimated $10.8K.
  • Okabena Investment Services first reported a position in ResMed in Q4 2021 and held it in 8 quarters.
  • Okabena Investment Services's ResMed position peaked at $1.67M in Q4 2022.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Okabena Investment Services's 13F filing for Q4 2023, filed 14 Feb 2024.